A GP surgery has announced it will leave its premises as the landlord wants to sell it
A GP surgery will have to move out of its building after failing to secure a long-term lease with the owners.
A letter was sent to patients on Friday morning informing them that Billinge Medical Practice will have to leave its premises on Recreation Drive.
It follows two years of “extensive” discussions with the building’s owners, who are former GP partners, and the drawing up of a grant proposal to improve the site.
The letter, signed by managing partner Erika Howell, said: “Billinge Medical Practice operates from a building owned by former GP partners who are now landlords of the property.


"Over the past two years, the practice has been working closely with the landlords, NHS colleagues and the integrated care board (ICB) to try to secure a long-term lease and access capital funding to improve the building.
"This work included extensive discussions and the development of a capital grant proposal that would have enabled improvements to the premises.
"Despite significant work from all parties involved, it has not been possible to reach an agreement that works for everyone. The landlords have now confirmed that they intend to sell the building and have issued notice to the practice to vacate the premises.
"We appreciate that this news may raise questions. This situation relates to the building rather than the practice itself. Billinge Medical Practice remains open and continues to provide care to our patients and the local community while we work with NHS England, the integrated care board and other partners to secure a suitable long-term premises solution.”
No timescale for the move was given, with patients told they should “continue to access care from the practice in the usual way”.
The health centre was previously put in special measures by the Care Quality Commission, after being rated as “inadequate” in 2023 due to patients struggling to get through to the surgery by phone and systems that did not identify, manage and mitigate risks.
But improvements were made and it was judged to be “good” in 2024, with the Patient Participation Group (PPG) hailing the turnaround as “nothing short of spectacular”.